Filing Details

Accession Number:
0001209191-21-018328
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-05 17:54:39
Reporting Period:
2021-03-04
Accepted Time:
2021-03-05 17:54:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662774 Cortexyme Inc. CRTX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1770790 David Lamond C/O Cortexyme, Inc.
269 East Grand Ave.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-04 16,621 $34.28 1,763,730 No 4 P Indirect By Blue Devil Trust dated 12/03/2010
Common Stock Acquisiton 2021-03-04 13,310 $35.00 1,777,040 No 4 P Indirect By Blue Devil Trust dated 12/03/2010
Common Stock Acquisiton 2021-03-04 15,969 $36.34 1,793,009 No 4 P Indirect By Blue Devil Trust dated 12/03/2010
Common Stock Acquisiton 2021-03-04 4,100 $36.86 1,797,109 No 4 P Indirect By Blue Devil Trust dated 12/03/2010
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Blue Devil Trust dated 12/03/2010
No 4 P Indirect By Blue Devil Trust dated 12/03/2010
No 4 P Indirect By Blue Devil Trust dated 12/03/2010
No 4 P Indirect By Blue Devil Trust dated 12/03/2010
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 301,829 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.75 to $34.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $34.75 to $35.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.75 to $36.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $36.76 to $36.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.